Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

11.17p
   
  • Change Today:
    -0.83p
  • 52 Week High: 39.50p
  • 52 Week Low: 10.78p
  • Currency: UK Pounds
  • Shares Issued: 412.47m
  • Volume: 1,310,751
  • Market Cap: £46.06m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
30-Jun-24 Interim 15.20 (13.80) (0.03)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 0.01 (18.62) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-20 9.43 (23.46) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-21 25.16 (30.34) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-22 27.20 (30.90) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-23 30.80 (24.50) (7.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 31.23 (22.89) (5.96)p n/a n/a n/a n/a 0.0%
31-Dec-25 27.47 (9.10) (3.94)p n/a n/a n/a n/a 0.0%
31-Dec-26 36.58 (12.03) (1.88)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

CREO Market Data

Currency UK Pounds
Share Price 11.17p
Change Today -0.83p
% Change -6.94 %
52 Week High 39.50p
52 Week Low 10.78p
Volume 1,310,751
Shares Issued 412.47m
Market Cap £46.06m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.53% above the market average27.53% above the market average27.53% above the market average27.53% above the market average27.53% above the market average
3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average
Price Trend
83% below the market average83% below the market average83% below the market average83% below the market average83% below the market average
62.16% below the sector average62.16% below the sector average62.16% below the sector average62.16% below the sector average62.16% below the sector average
Income Not Available
Growth
26.63% above the market average26.63% above the market average26.63% above the market average26.63% above the market average26.63% above the market average
41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 07-Apr-2025

Time Volume / Share Price
14:02 5,000 @ 11.05p
13:45 9 @ 11.25p
13:45 12 @ 11.25p
13:45 9 @ 11.25p
13:45 447 @ 11.25p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page